@article{79019e21150d45509b1f000149af91d4,
title = "Definition, course, and outcome of mild cognitive impairment",
abstract = "Mild Cognitive Impairment (MCI) is a term which can be applied to a boundary area between dementia and normal aging. Criteria which reliably describe persons falling in this range of the cognitive continuum can be defined. These persons are at very high risk for developing dementia. Biologic and cognitive parameters including Apolipoprotein E genotype help to differentiate MCI persons who will progress to dementia in 2-4 years from those who will remain free from dementia over this interval.",
author = "Smith, {Glenn E.} and Petersen, {Ronald C.} and Parisi, {Joseph E.} and Ivnik, {Robert J.} and Emre Kokmen and Tangalos, {Eric G.} and Stephen Waring",
note = "Funding Information: * Glenn E. Smith, Department of Psychiatry and Psychology; Ronald C. Petersen, Department of Neurology; Joseph E. Parisi, Department of Pathology; Robert J. Ivnik, Department of Psychiatry and Psychology; Emre Kokmen, Department of Neurology; Eric G. Tangalos, Division of Community Internal Medicine; and Stephen Waring, Department of Health Sciences Research. An earlier version of this paper was presented at the International Neuropsychology Society Annual Meeting, February 8-1 l, 199.5, at Seattle, Washington. Portions of this research have been supported by National Institute on Aging grants AG06786, AG08031, and AG11638 and a grant by Glaxo, Inc. The authors wish to acknowledge the assistance of the staff of the Mayo Clinic Alzheimer{\textquoteright}s Disease Center. Address correspondence to: Glenn Smith, Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN 55905, USA. Accepted for publication: November 27, 1995.",
year = "1996",
month = jun,
doi = "10.1080/13825589608256619",
language = "English (US)",
volume = "3",
pages = "141--147",
journal = "Aging, Neuropsychology, and Cognition",
issn = "1382-5585",
publisher = "Psychology Press Ltd",
number = "2",
}